Try our Advanced Search for more refined results

Bristol-Meyers May Slash Non-Californians From Ongylza Row

By Cara Bayles ( October 3, 2016, 11:38 PM EDT) -- A San Francisco judge said at a hearing Monday he'll likely deny Bristol-Meyers Squibb Co. and Astrazeneca Pharmaceuticals LP's bid to end two product liability suits over the diabetes drug Onglyza on the grounds that the majority of plaintiffs don't live in California, but said he'll probably dismiss out-of-state litigants....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!